Why is calling an ACE an ACE so controversial? Evaluating reference-based pricing in British Columbia

Anis, Aslam
March 2002
CMAJ: Canadian Medical Association Journal;3/19/2002, Vol. 166 Issue 6, p763
Academic Journal
Comments on the practice of reference-based drug pricing for angiotensin-converting enzyme (ACE) inhibitors in British Colombia. Use of population-based data from government prescription drug programs to assess the effects of ACE inhibitors in the treatment of hypertension; Discussion of the use of copayments.


Related Articles

  • Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines. Frisk, Pia; Mellgren, Tor-Olov; Hedberg, Niklas; Berlin, Anita; Granath, Fredrik; Wettermark, Björn // European Journal of Clinical Pharmacology;Dec2008, Vol. 64 Issue 12, p1223 

    Angiotensin receptor blockers (ARBs) offer a new treatment alternative for patients with hypertension and heart failure. Due to comparatively high prices, most guidelines suggest ARBs be restricted to patients intolerant to angiotensin-converting enzyme inhibitors (ACEi). We analysed the...

  • Change in advice on hypertension. Hartley, Jo // GP: General Practitioner;10/21/2002, p7 

    Discusses the change in general practitioners' advice for hypertension patients. Prescription of first-line drugs depending on a patient's age; Suggestion for use of angiotensin converting enzyme inhibitors, betablockers, calcium channel blockers and diuretics for prescription of drugs to...

  • What a difference a dot makes.  // Cortlandt Forum;08/25/97, Vol. 10 Issue 8, p79 

    Comments on a discussion for the serial treatment of hypertension with angiotensin-converting enzyme (ACE) inhibitors. Atenolol is a beta blocker and clonidine with the ACE inhibitors.

  • ACE Inhibitors: Review of Four New Agents. Binder, S. Bruce // American Family Physician;10/1/1993, Vol. 48 Issue 5, p851 

    Features four angiotensin converting enzyme inhibitors approved in the United States for treatment of hypertension. Benazepril; Fosinopril; Quinapril; Ramipril; Therapeutic effectiveness; Elimination; Adverse effects; Cost.

  • New advice: Higher-dose ACE inhibitors OK for Africa-Americans.  // Geriatrics;Oct95, Vol. 50 Issue 10, p16 

    Reports that raising the dose of angiotensin converting enzyme (ACE) inhibitors appear to enhance their effectiveness in African-American hypertension patients. Conventional basis of decisions in antihypertensive therapy for Afro-Americans; Focus on the added benefits of ACE inhibitors.

  • Eprosartan: A Viewpoint by William H. Frishman. Frishman, W.H. // Drugs;May1998, Vol. 55 Issue 5, p719 

    Presents information on eprosartan, a drug approved in the U.S. for use in hypertension. Results of clinical trials; Combination of angiotensin-converting enzyme inhibitors with angiotensin II receptor blockers.

  • CARDIOVASCULAR SYSTEM.  // MPR - Pharmacist's Edition;Winter2009/2010, Vol. 3 Issue 4, p4 

    The article offers information about drugs for hypertension, with their effectiveness, precautions and dosage of intake. It notes that the hypotensive effect of thiazides and its associated diuretics is mediated by arteriolar vasodilatation with greatest effect at low dose. The angiotensin...

  • The angiotensin converting enzyme inhibitors - alternative clinical applications. Stanisz, Beata; Regulska, Katarzyna; Regulski, Miłosz // Journal of Medical Science;2014, Vol. 1, p57 

    Angiotensin converting enzyme inhibitors have emerged as a useful strategy in the management of hypertension and other cardiovascular system-related diseases. However, a wide range of their biological effects has turned the scientific interest towards other possible clinical applications of...

  • SECTION 2: CARDIOVASCULAR SYSTEM.  // MPR - Obstetrician & Gynecologist Edition;Fall/Winter2011, Vol. 22 Issue 2, p2 

    The article offers brief information on several medications for cardiovascular diseases including Accupril, Aceon, and Benicar. Accupril, an angiotensin converting enzyme (ACE) inhibitor, from Pfizer Inc. is indicated for hypertension, particularly for monotherapy. Aceon from Abbott Laboratories...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics